Report Detail
Europe Chronic Idiopathic Constipation (CIC) Drugs Market Report 2018
- RnM2965747 |
- 18 February, 2019 |
- Global |
- 111 Pages |
- XYZResearch |
- Pharma & Healthcare
Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Chronic Idiopathic Constipation (CIC) Drugs for these regions, from 2012 to 2023 (forecast), including
Germany
UK
France
Russia
Benelux
Italy
Spain
Europe Chronic Idiopathic Constipation (CIC) Drugs market competition by top manufacturers/players, with Chronic Idiopathic Constipation (CIC) Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Actavis
Chugai Pharmaceutical
Ferring International Center S.A.
Synergy Pharmaceuticals
Pfizer
GlaxoSmithKline
Roche Holding AG
Sanofi
Bayer AG
Salix Pharmaceuticals Ltd
Sucampo Pharmaceuticals Inc
Ironwood Pharmaceuticals
Progenics Pharmaceuticals
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Lubiprostone
Linaclotide
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Chronic Idiopathic Constipation (CIC) Drugs for each application, including
Hospitals & Clinics
Ambulatory Surgical Centres
Long Term Care Centres
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Report Overview
- 1.1 Definition and Specification
- 1.2 Report Overview
- 1.2.1 Manufacturers Overview
- 1.2.2 Regions Overview
- 1.2.3 Type Overview
- 1.2.4 Application Overview
- 1.3 Industrial Chain
- 1.3.1 Chronic Idiopathic Constipation (CIC) Drugs Overall Industrial Chain
- 1.3.2 Upstream
- 1.3.3 Downstream
- 1.4 Industry Situation
- 1.4.1 Industrial Policy
- 1.4.2 Product Preference
- 1.4.3 Economic/Political Environment
- 1.5 SWOT Analysis
2 Market Analysis by Types
- 2.1 Overall Market Performance(Volume)
- 2.1.1 Lubiprostone Market Performance (Volume)
- 2.1.2 Linaclotide Market Performance (Volume)
- 2.1.3 Others Market Performance (Volume)
- 2.2 Overall Market Performance(Value)
- 2.1.1 Lubiprostone Market Performance (Value)
- 2.1.2 Linaclotide Market Performance (Value)
- 2.1.3 Others Market Performance (Value)
3 Product Application Market
- 3.1 Overall Market Performance (Volume)
- 3.1.1 Hospitals & Clinics Market Performance (Volume)
- 3.1.2 Ambulatory Surgical Centres Market Performance (Volume)
- 3.1.3 Long Term Care Centres Market Performance (Volume)
- 3.1.4 Others Market Performance (Volume)
4 Manufacturers Profiles/Analysis
- 4.1 Actavis
- 4.1.1 Actavis Profiles
- 4.1.2 Actavis Product Information
- 4.1.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Business Performance
- 4.1.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Business Development and Market Status
- 4.2 Chugai Pharmaceutical
- 4.2.1 Chugai Pharmaceutical Profiles
- 4.2.2 Chugai Pharmaceutical Product Information
- 4.2.3 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Business Performance
- 4.2.4 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Business Development and Market Status
- 4.3 Ferring International Center S.A.
- 4.3.1 Ferring International Center S.A. Profiles
- 4.3.2 Ferring International Center S.A. Product Information
- 4.3.3 Ferring International Center S.A. Chronic Idiopathic Constipation (CIC) Drugs Business Performance
- 4.3.4 Ferring International Center S.A. Chronic Idiopathic Constipation (CIC) Drugs Business Development and Market Status
- 4.4 Synergy Pharmaceuticals
- 4.4.1 Synergy Pharmaceuticals Profiles
- 4.4.2 Synergy Pharmaceuticals Product Information
- 4.4.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Business Performance
- 4.4.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Business Development and Market Status
- 4.5 Pfizer
- 4.5.1 Pfizer Profiles
- 4.5.2 Pfizer Product Information
- 4.5.3 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Business Performance
- 4.5.4 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Business Development and Market Status
- 4.6 GlaxoSmithKline
- 4.6.1 GlaxoSmithKline Profiles
- 4.6.2 GlaxoSmithKline Product Information
- 4.6.3 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Business Performance
- 4.6.4 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Business Development and Market Status
- 4.7 Roche Holding AG
- 4.7.1 Roche Holding AG Profiles
- 4.7.2 Roche Holding AG Product Information
- 4.7.3 Roche Holding AG Chronic Idiopathic Constipation (CIC) Drugs Business Performance
- 4.7.4 Roche Holding AG Chronic Idiopathic Constipation (CIC) Drugs Business Development and Market Status
- 4.8 Sanofi
- 4.8.1 Sanofi Profiles
- 4.8.2 Sanofi Product Information
- 4.8.3 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Business Performance
- 4.8.4 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Business Development and Market Status
- 4.9 Bayer AG
- 4.9.1 Bayer AG Profiles
- 4.9.2 Bayer AG Product Information
- 4.9.3 Bayer AG Chronic Idiopathic Constipation (CIC) Drugs Business Performance
- 4.9.4 Bayer AG Chronic Idiopathic Constipation (CIC) Drugs Business Development and Market Status
- 4.10 Salix Pharmaceuticals Ltd
- 4.10.1 Salix Pharmaceuticals Ltd Profiles
- 4.10.2 Salix Pharmaceuticals Ltd Product Information
- 4.10.3 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation (CIC) Drugs Business Performance
- 4.10.4 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation (CIC) Drugs Business Development and Market Status
- 4.11 Sucampo Pharmaceuticals Inc
- 4.12 Ironwood Pharmaceuticals
- 4.13 Ferring International Center S.A.
5 Market Performance for Manufacturers
- 5.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) and Market Share by Manufacturers 2013-2018
- 5.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue (M USD) and Market Share by Manufacturers 2013-2018
- 5.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
- 5.4 Europe Chronic Idiopathic Constipation (CIC) Drugs Gross Margin of Manufacturers 2013-2018
- 5.5 Market Concentration
6 Regions Market Performance for Manufacturers
- 6.1 Germany Market Performance for Manufacturers
- 6.1.1 Germany Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
- 6.1.2 Germany Chronic Idiopathic Constipation (CIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
- 6.1.3 Germany Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
- 6.1.4 Germany Chronic Idiopathic Constipation (CIC) Drugs Gross Margin of Manufacturers 2013-2018
- 6.1.5 Market Concentration
- 6.2 UK Market Performance for Manufacturers
- 6.2.1 UK Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
- 6.2.2 UK Chronic Idiopathic Constipation (CIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
- 6.2.3 UK Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
- 6.2.4 UK Chronic Idiopathic Constipation (CIC) Drugs Gross Margin of Manufacturers 2013-2018
- 6.2.5 Market Concentration
- 6.3 France Market Performance for Manufacturers
- 6.3.1 France Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
- 6.3.2 France Chronic Idiopathic Constipation (CIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
- 6.3.3 France Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
- 6.3.4 France Chronic Idiopathic Constipation (CIC) Drugs Gross Margin of Manufacturers 2013-2018
- 6.3.5 Market Concentration
- 6.4 Russia Market Performance for Manufacturers
- 6.4.1 Russia Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
- 6.4.2 Russia Chronic Idiopathic Constipation (CIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
- 6.4.3 Russia Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
- 6.4.4 Russia Chronic Idiopathic Constipation (CIC) Drugs Gross Margin of Manufacturers 2013-2018
- 6.4.5 Market Concentration
- 6.5 Benelux Market Performance for Manufacturers
- 6.5.1 Benelux Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
- 6.5.2 Benelux Chronic Idiopathic Constipation (CIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
- 6.5.3 Benelux Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
- 6.5.4 Benelux Chronic Idiopathic Constipation (CIC) Drugs Gross Margin of Manufacturers 2013-2018
- 6.5.5 Market Concentration
- 6.6 Italy Market Performance for Manufacturers
- 6.6.1 Italy Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
- 6.6.2 Italy Chronic Idiopathic Constipation (CIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
- 6.6.3 Italy Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
- 6.6.4 Italy Chronic Idiopathic Constipation (CIC) Drugs Gross Margin of Manufacturers 2013-2018
- 6.6.5 Market Concentration
- 6.7 Spain Market Performance for Manufacturers
- 6.7.1 Spain Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
- 6.7.2 Spain Chronic Idiopathic Constipation (CIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
- 6.7.3 Spain Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
- 6.7.4 Spain Chronic Idiopathic Constipation (CIC) Drugs Gross Margin of Manufacturers 2013-2018
- 6.7.5 Market Concentration
- 6.8 Market Performance for Manufacturers
- 6.8.1 Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
- 6.8.2 Chronic Idiopathic Constipation (CIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
- 6.8.3 Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
- 6.8.4 Chronic Idiopathic Constipation (CIC) Drugs Gross Margin of Manufacturers 2013-2018
- 6.8.5 Market Concentration
7 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Performance (Sales Point)
- 7.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) and Market Share by Regions 2013-2018
- 7.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue (M USD) and Market Share by Regions 2013-2018
- 7.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) by Regions 2013-2018
- 7.4 Europe Chronic Idiopathic Constipation (CIC) Drugs Gross Margin by Regions 2013-2018
8 Development Trend for Regions (Sales Point)
- 8.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
- 8.2 Germany Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
- 8.3 UK Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
- 8.4 France Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
- 8.5 Russia Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
- 8.6 Benelux Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
- 8.7 Italy Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
- 8.8 Spain Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
- 8.8 Spain Chronic Idiopathic Constipation (CIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
9 Upstream Source, Technology and Cost
- 9.1 Upstream Source
- 9.2 Technology
- 9.3 Cost
10 Channel Analysis
- 10.1 Market Channel
- 10.2 Distributors
11 Consumer Analysis
- 11.1 Hospitals & Clinics Industry
- 11.2 Ambulatory Surgical Centres Industry
- 11.3 Long Term Care Centres Industry
12 Market Forecast 2019-2024
- 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
- 12.1.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
- 12.1.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) and Growth Rate 2019-2024
- 12.1.3 Germany Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
- 12.1.4 UK Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
- 12.1.5 France Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
- 12.1.6 Russia Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
- 12.1.7 Benelux Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
- 12.1.8 Italy Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
- 12.1.9 Spain Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
- 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
- 12.3.1 Overall Market Performance
- 12.3.2 Lubiprostone Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
- 12.3.3 Linaclotide Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
- 12.3.4 Others Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
- 12.4 Sales by Application 2019-2024
- 12.4.1 Overall Market Performance
- 12.4.2 Hospitals & Clinics Sales and and Growth Rate 2019-2024
- 12.4.3 Ambulatory Surgical Centres Sales and and Growth Rate 2019-2024
- 12.4.4 Long Term Care Centres Sales and and Growth Rate 2019-2024
- 12.4.5 Others Sales and and Growth Rate 2019-2024
- 12.5 Price (USD/Unit) and Gross Profit
- 12.5.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Price (USD/Unit) Trend 2019-2024
- 12.5.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Gross Profit Trend 2019-2024
13 Conclusion
Summary:
Get latest Market Research Reports on Chronic Idiopathic Constipation (CIC) Drugs. Industry analysis & Market Report on Chronic Idiopathic Constipation (CIC) Drugs is a syndicated market report, published as Europe Chronic Idiopathic Constipation (CIC) Drugs Market Report 2018. It is complete Research Study and Industry Analysis of Chronic Idiopathic Constipation (CIC) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
